These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 15623618)
21. Expression and immunogenicity of NY-ESO-1 in hepatocellular carcinoma. Nakamura S; Nouso K; Noguchi Y; Higashi T; Ono T; Jungbluth A; Chen YT; Old LJ; Nakayama E; Shiratori Y J Gastroenterol Hepatol; 2006 Aug; 21(8):1281-5. PubMed ID: 16872310 [TBL] [Abstract][Full Text] [Related]
22. Tumor antigen expression in melanoma varies according to antigen and stage. Barrow C; Browning J; MacGregor D; Davis ID; Sturrock S; Jungbluth AA; Cebon J Clin Cancer Res; 2006 Feb; 12(3 Pt 1):764-71. PubMed ID: 16467087 [TBL] [Abstract][Full Text] [Related]
23. [Expression of multiple cancer-testis antigen genes in non-small cell lung cancer treated by chemotherapy prior surgery]. Wang Y; Liang Z; Yuan YH; Han Y; Liu YX; Liu N; Chen YT; Ritter G; Old LJ; Zhang LJ Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):464-8. PubMed ID: 15061963 [TBL] [Abstract][Full Text] [Related]
24. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance. Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224 [TBL] [Abstract][Full Text] [Related]
25. Cancer/testis antigen expression and autologous humoral immunity to NY-ESO-1 in gastric cancer. Wang Y; Wu XJ; Zhao AL; Yuan YH; Chen YT; Jungbluth AA; Gnjatic S; Santiago D; Ritter G; Chen WF; Old LJ; Ji JF Cancer Immun; 2004 Nov; 4():11. PubMed ID: 15516106 [TBL] [Abstract][Full Text] [Related]
26. Identification of NY-ESO-1, MAGE-1, and MAGE-3 in head and neck squamous cell carcinoma. Kienstra MA; Neel HB; Strome SE; Roche P Head Neck; 2003 Jun; 25(6):457-63. PubMed ID: 12784237 [TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in squamous cell carcinoma of the penis. Hudolin T; Juretic A; Pasini J; Tomas D; Spagnoli GC; Heberer M; Dimanovski J; Kruslin B Urology; 2006 Jul; 68(1):205-7. PubMed ID: 16806422 [TBL] [Abstract][Full Text] [Related]
29. Expression in childhood primary brain tumors of NY-ESO-1, a cancer/testis antigen: an immunohistochemical study. Bodey B; Bodey V; Siegel SE In Vivo; 2008; 22(1):83-7. PubMed ID: 18396787 [TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Jungbluth AA; Chen YT; Stockert E; Busam KJ; Kolb D; Iversen K; Coplan K; Williamson B; Altorki N; Old LJ Int J Cancer; 2001 Jun; 92(6):856-60. PubMed ID: 11351307 [TBL] [Abstract][Full Text] [Related]
31. NY-ESO-1 tumour associated antigen is a cytoplasmic protein detectable by specific monoclonal antibodies in cell lines and clinical specimens. Schultz-Thater E; Noppen C; Gudat F; Dürmüller U; Zajac P; Kocher T; Heberer M; Spagnoli GC Br J Cancer; 2000 Jul; 83(2):204-8. PubMed ID: 10901371 [TBL] [Abstract][Full Text] [Related]
32. Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer. Gure AO; Chua R; Williamson B; Gonen M; Ferrera CA; Gnjatic S; Ritter G; Simpson AJ; Chen YT; Old LJ; Altorki NK Clin Cancer Res; 2005 Nov; 11(22):8055-62. PubMed ID: 16299236 [TBL] [Abstract][Full Text] [Related]
33. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms. Yakirevich E; Sabo E; Lavie O; Mazareb S; Spagnoli GC; Resnick MB Clin Cancer Res; 2003 Dec; 9(17):6453-60. PubMed ID: 14695148 [TBL] [Abstract][Full Text] [Related]
34. [Correlation of NY-ESO-1 gene and protein expression to metastasis and clinicopathologic features of hepatocellular carcinoma]. Zhang WM; Xiao G; Xie D; Zhang M; Guo AL; Wen JM Ai Zheng; 2005 May; 24(5):622-6. PubMed ID: 15890110 [TBL] [Abstract][Full Text] [Related]
35. Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma. Errington JA; Conway RM; Walsh-Conway N; Browning J; Freyer C; Cebon J; Madigan MC Br J Ophthalmol; 2012 Mar; 96(3):451-8. PubMed ID: 22190731 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of LAGE-1 and NY-ESO-1 expression in multiple myeloma patients to explore possible benefits of their homology for immunotherapy. de Carvalho F; Vettore AL; Inaoka RJ; Karia B; Andrade VC; Gnjatic S; Jungbluth AA; Colleoni GW Cancer Immun; 2011 Jan; 11():1. PubMed ID: 21247062 [TBL] [Abstract][Full Text] [Related]
37. NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabine. Pollack SM; Li Y; Blaisdell MJ; Farrar EA; Chou J; Hoch BL; Loggers ET; Rodler E; Eary JF; Conrad EU; Jones RL; Yee C PLoS One; 2012; 7(2):e32165. PubMed ID: 22384167 [TBL] [Abstract][Full Text] [Related]
38. Immunomic analysis of human sarcoma. Lee SY; Obata Y; Yoshida M; Stockert E; Williamson B; Jungbluth AA; Chen YT; Old LJ; Scanlan MJ Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2651-6. PubMed ID: 12601173 [TBL] [Abstract][Full Text] [Related]
39. Melanoma or not? Cancer testis antigens may help. Lüftl M; Schuler G; Jungbluth AA Br J Dermatol; 2004 Dec; 151(6):1213-8. PubMed ID: 15606517 [TBL] [Abstract][Full Text] [Related]
40. Expression and clinical relevance of NY-ESO-1, MAGE-1 and MAGE-3 in neuroblastoma. Söling A; Schurr P; Berthold F Anticancer Res; 1999; 19(3B):2205-9. PubMed ID: 10472332 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]